Objective: To compare the effects of early and late use of milrinone in children upto 1 year undergoing complex cardiac surgery. Study design:- prospective randomized study. Methods:
A prospective study involved 30 children undergoing congenital corrective cardiac surgery,classified randomly into two groups. Group A: Milrinone infusion was started without loading dose at 0.5mcg/kg/min at the beginning of CPB and continued postoperatively (0.5-0.75 mcg/kg/min) in the paediatric cardiac surgical ICU . Group B: Milrinone was started as a loading dose of 50mcg/kg over 10 min after aortic declamping and continued as infusion postoperatively at 0.5-0.75 mcg/kg/min in the pediatric cardiac surgical ICU.Data were collected at baseline, 1st ,6th and 12th postoperative hours in the ICU. Results: The inotropic supports and mechanical supports were needed more in group B than group A. The comparison of heart rate, CVP were insignificant between the two groups (P>0.05). The mean arterial blood pressure through the first 6 hours postoperatively was higher in group A than group B (P<0.05), but became insignificant through other timepoints. The urine output and central venous oxygen saturation were higher in group A than group B (P<0.05).The serum lactate levels were significantly higher in group B more than group A (P<0.05). Conclusion:Early use of milrinone, lead to easy weaning from Cardiopulmonary bypass, decreased requirement of pharmacological and mechanical support and decreased incidence of low cardiac output syndrome after pediatric cardiac surgery and there was no complications related to milrinone in our study patients.
Wernovsky G, Wypij D, Jonas RA, Mayer JE, Jr., Hanley FL, Hickey PR Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 1995;92;(8.);2226-35.
Chandler HK, Kirsh R.Management of the Low Cardiac Output Syndrome Following Surgery for Congenital Heart Disease.Curr Cardiol Rev.2016;12(2):107-111.
Lobos A-T., Lee S., Menon K. Capillary refill time and cardiac output in children undergoing cardiac catheterization. Pediatr. Crit. Care Med. 2012;13(2):136–140. doi: 10.1097/PCC.0b013e31 8220afdc.
Kikura M, Sato S. The efficacy of preemptive Milrinone or Amrinone therapy in patients undergoing coronary artery bypass grafting. 2002 Jan;94(1):22-30.
Kauffman RF, Schenck KW, Utterback BG, Crowe VG, Cohen ML: In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides. J Pharmacol Exp Ther 1987; 242;(3.);864-72.
Polla B, Cappelli V, Canepari M, Zanardi M C, Reggiani C: Direct depressant effect of phosphodiesterase inhibitors on ATPase activity of rat cardiac myofibrils. Can J Physiol Pharmacol 1995; 73;(5.);661-4.
Ringe HI, Varnholt V, Gaedicke G: Cardiac rescue with enoximone in volume and catecholamine refractory septic shock. Pediatr Crit Care Med 2003; 4;(4.);471-5.
Chong LYZ, Satya K, Kim B, Berkowitz R. Milrinone Dosing and a Culture of Caution in Clinical Practice. Cardiol Rev. 2018 Jan/Feb;26(1):35-42.
Hoffman TM, Wernovsky G, Atz AM, Kulik TJ, Nelson DP, Chang AC, Bailey JM, Akbary A, Kocsis JF, Kaczmarek R, Spray TL. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation. 2003 Feb 25;107(7):996-1002.
Soliman R, Yousef H, Ragheb A, Al Qethamy H, Alghadam F, Elgamal G. Comparison of early and late intravenous infusion of milrinone in pediatric patients undergoing cardiac surgery. J Anesthesiol Clin Sci. 2012;1:6-12.
Zuppa AF, Nicolson SC, Adamson PC, Wernovsky G, Mondick JT et al.: Population pharmacokinetics of milrinone in neonates with hypoplastic left heart syndrome undergoing stage I reconstruction. Anesth Analg 2006; 102;(4.);1062-9.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright (c) 2020 Array